Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Osteoarthritis symbols : SRNE save search
Sorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) for the Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
Published: 2023-09-07 (Crawled : 13:00) - globenewswire.com
SRNE | $0.015 -25.0% -8.85% 140K
|
Health Technology
|
| O: 0.52%
H: 42.58%
C: 36.03%
osteoarthritis positive treatment trial therapeutics results
Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin (RTX) for Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
Published: 2022-09-26 (Crawled : 14:00) - biospace.com/
SRNE | $0.015 -25.0% -8.85% 140K
|
Health Technology
|
| O: -0.65%
H: 5.19%
C: -1.95%
treatment osteoarthritis trial therapeutics phase 2
Sorrento Begins Enrollment in Phase 2 Trial of Resiniferatoxin (RTX) for the Treatment of Pain Due to Knee Osteoarthritis (OA)
Published: 2021-12-07 (Crawled : 19:00) - globenewswire.com
SRNE | $0.015 -25.0% -8.85% 140K
|
Health Technology
|
| O: -1.68%
H: 9.4%
C: 7.52%
treatment phase 2 xin osteoarthritis trial enroll
FDA Clears Sorrento Phase 2 Trial Of Non-Opioid Product Candidate Resiniferatoxin (RTX) For Treatment of the Knee Pain in Osteoarthritis (OA) Patients
Published: 2021-07-06 (Crawled : 19:00) - globenewswire.com
SRNE | $0.015 -25.0% -8.85% 140K
|
Health Technology
|
| O: -1.05%
H: 1.06%
C: -12.02%
treatment fda phase 2 opioid osteoarthritis trial fda clearance
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
MNTS | $0.5 35.69% 26.3% 4.7M
|
PROK | $2.72 33.33% 24.58% 2.6M
|
MIGI | $1.57 31.93% 24.2% 660K
|
Information
LIFW | $1.22 28.69% 22.93% 2.8M
|
Administrative and Support and ...
PHIO | News | $0.8299 29.69% 22.63% 7M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.